PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...

(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...

Recent price moves and business snapshot Genscript Biotech (SEHK:1548) has seen the stock slip about 0.5% on the day and roughly 5.6% over the past week, while posting a gain of around 13% over the ...

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...

The two biotech leaders have embarked on a research project to streamline manufacturing The two biotech leaders have embarked on a research project to streamline manufacturing GenScript – the ...

GenScript ProBio is the subsidiary of GenScript Biotech Corp. (HK.1548), building upon GenScript’s solid gene synthesis technology and deep expertise in the antibody, cell, and gene therapy fields, ...

Join us as we delve into the forefront of SARS-CoV-2 diagnostics and GenScript's transformative impact in the fight against COVID-19. We'll discuss the emergence of COVID-19 and GenScript's rapid ...

No-moat GenScript’s 01548 full-year results were in line with our expectations. Companywide revenue for the year was within 2% of our expectations. However, revenue growth from the non-cell therapy ...

GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...

PISCATAWAY, N.J. & NEW YORK--(BUSINESS WIRE)--GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy ...